Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manabu Okada

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Vitamins and Hormones|August 11, 2022
Renal hyperparathyroidismAiji Yajima, Ken Tsuchiya, Makoto Kuro-O, et al.
Current Urology|August 23, 2024
Which characteristics are associated with changes in medication status for lower urinary tract symptoms among patients with prostate cancer receiving external beam radiotherapy?Yuki Kyoda, Kohei Hashimoto, Atsushi Takahashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 3, 2021
Therapeutic options to reduce intravesical recurrence in newly diagnosed Ta high-grade bladder cancer according to risk stratification: A multicenter retrospective studyTetsuya Shindo, Kohei Hashimoto, Toshiaki Tanaka, et al.
Human Immunology|November 13, 2024
Which is more important for predicting de novo DSA production in donor-sensitized kidney transplant recipients, B-cell epitope or T-cell epitope analysis?Satoshi Ashimine, Shintaro Sakamoto, Toshihide Tomosugi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 10, 2021
The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled studyYohei Doi, Makoto Tsujita, Takayuki Hamano, et al.
Journal of Geriatric Oncology|January 10, 2025
Efficacy and safety of enfortumab vedotin in older patients with metastatic urothelial carcinoma: A multicenter retrospective studyTetsuya Shindo, Kohei Hashimoto, Toshiki Kenuka, et al.
Urology|February 13, 2026
Association Between Behavioral Change and Nocturia Improvement: A Multicenter Analysis Using a Self-Check SheetYuki Kyoda, Atsushi Wanifuchi, Ippei Muranaka, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 11, 2022
A Novel Method of CD31-Combined ABO Carbohydrate Antigen Microarray Predicts Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney TransplantationMasayuki Tasaki, Hiroaki Tateno, Takashi Sato, et al.
Clinical Transplantation|March 28, 2022
Two-year outcomes of low-exposure extended-release tacrolimus and mycophenolate mofetil regimen in de novo kidney transplantation: A multi-center randomized controlled trialYuji Hidaka, Norihiko Goto, Shigeyoshi Yamanaga, et al.
Anticancer Research|February 29, 2024
Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based ChemotherapyTetsuya Shindo, Kohei Hashimoto, Atsushi Takahashi, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Vitamins and Hormones|August 11, 2022
Renal hyperparathyroidismAiji Yajima, Ken Tsuchiya, Makoto Kuro-O, et al.
Current Urology|August 23, 2024
Which characteristics are associated with changes in medication status for lower urinary tract symptoms among patients with prostate cancer receiving external beam radiotherapy?Yuki Kyoda, Kohei Hashimoto, Atsushi Takahashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 3, 2021
Therapeutic options to reduce intravesical recurrence in newly diagnosed Ta high-grade bladder cancer according to risk stratification: A multicenter retrospective studyTetsuya Shindo, Kohei Hashimoto, Toshiaki Tanaka, et al.
Human Immunology|November 13, 2024
Which is more important for predicting de novo DSA production in donor-sensitized kidney transplant recipients, B-cell epitope or T-cell epitope analysis?Satoshi Ashimine, Shintaro Sakamoto, Toshihide Tomosugi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 10, 2021
The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled studyYohei Doi, Makoto Tsujita, Takayuki Hamano, et al.
Journal of Geriatric Oncology|January 10, 2025
Efficacy and safety of enfortumab vedotin in older patients with metastatic urothelial carcinoma: A multicenter retrospective studyTetsuya Shindo, Kohei Hashimoto, Toshiki Kenuka, et al.
Urology|February 13, 2026
Association Between Behavioral Change and Nocturia Improvement: A Multicenter Analysis Using a Self-Check SheetYuki Kyoda, Atsushi Wanifuchi, Ippei Muranaka, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 11, 2022
A Novel Method of CD31-Combined ABO Carbohydrate Antigen Microarray Predicts Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney TransplantationMasayuki Tasaki, Hiroaki Tateno, Takashi Sato, et al.
Clinical Transplantation|March 28, 2022
Two-year outcomes of low-exposure extended-release tacrolimus and mycophenolate mofetil regimen in de novo kidney transplantation: A multi-center randomized controlled trialYuji Hidaka, Norihiko Goto, Shigeyoshi Yamanaga, et al.
Anticancer Research|February 29, 2024
Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based ChemotherapyTetsuya Shindo, Kohei Hashimoto, Atsushi Takahashi, et al.
Pageof 10